This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Top and Flop ETFs Last Week
by Sanghamitra Saha
These ETFs gained/lost the most amid the market blood bath last week.
Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DEF
Coronavirus Triggers Market Bloodbath: 7 Hot Inverse ETF Areas
by Sanghamitra Saha
A rise in coronavirus cases outside China has intensified the scare for global markets. These inverse ETFs posted solid gains.
COVID-19 Spreads Worldwide, Pre-Markets Plunge
by Mark Vickery
Major stock market futures are down precipitously at this hour in today's pre-market, as new information related to the COVID-19 coronavirus exacerbates the perceived risk to human life and economic growth.
Update on COVID-19 & "The Next Recession"
by Mark Vickery
There are no reported new countries where the Wuhan coronavirus -- COVID-19 -- appears to have spread as of today, though the death toll as well as the number of confirmed cases continues northward.
Solar & Large-Cap Growth: 2 ETFs to Watch on Outsized Volume
by Sanghamitra Saha
TAN and SPYG saw massive trading volumes in yesterday's trading session.
Big Gains in Housing Starts, Building Permits, PPI
by Mark Vickery
January Housing Starts, Building Permits and Producer Price Index all blew away estimates this morning.
Coronavirus to Hurt Apple Earnings: Time to Buy These ETFs?
by Sanghamitra Saha
Production delays and lower demand caused by coronavirus are likely to affect Apple???s earnings results. Buy the likely dip in Apple???s shares with these ETFs.
4 Best Leveraged ETFs of Last Week
by Sanghamitra Saha
Inside the top-performing leveraged ETFs of last week.
QQQ: Superstar ETF of the Decade; Here???s Why
by Neena Mishra
Here's what investors need to know about QQQ, one of the best performing ETF of the past decade.
Econ Data, Coronavirus Assessment Ahead of 3-Day Weekend
by Mark Vickery
With a three-day weekend ahead of us and few concrete answers regarding the COVID-19 coronavirus, it may be difficult for stocks to hold onto the slight positive sentiment.
Europe & Bear Emerging Markets: 2 ETFs to Watch on Outsized Volume
by Sanghamitra Saha
Europe and bear leveraged emerging market ETF witnessed considerable trading volume on Tuesday.
Are U.S. Assets Acting as Safe Havens? ETFs in Focus
by Sanghamitra Saha
Amid rising tension due to the coronavirus outbreak, U.S. broad-based assets and the related ETFs are acting as safe havens.
These 4 Sector ETFs Look Attractive in February
by Sanghamitra Saha
These Sector ETFs are well-positioned for a rally, thanks to strong fundamentals.
Best & Worst Leveraged ETFs of Last Week
by Sanghamitra Saha
Inside the top-and-worst-performing leveraged ETFs of last week.
Jobs Growth Stays Buoyant: 225K, Unemployment 3.6%
by Mark Vickery
225K was well beyond the analyst consensus of around 160K, and well above the upwardly revised 147K for December.
3 Key Investment Themes: Zacks FEB Market Strategy
by John Blank
Where institutional money flows are where stock returns rise. This month, after I followed the money, I focused on visible long-term investing themes. Here are three worth knowing about...
Will Virus Infect Q1 Earnings? Multi-Asset ETFs to Play
by Sanghamitra Saha
Coronavirus may weigh on global earnings in the first quarter and hurt equity markets. Should you try high-yielding multi-asset ETFs now?
5 Red Hot Stocks That Drove Nasdaq ETF to New Highs
by Sweta Killa
The Nasdaq Composite Index reached another all-time high driven by China's stimulus measures.
January ETF Asset Report: U.S. Equities Win
by Sanghamitra Saha
Investors poured money into U.S. equities and investment-grade bond ETFs in January.
Inverse Leverage S&P 500 & U.S. Treasury: 2 ETFs to Watch on Outsized Volume
by Sanghamitra Saha
Inverse Leveraged S&P 500 ETF and intermediate U.S. treasury ETF witnessed considerable trading volume on Friday.
Best & Worst ETFs of Coronavirus-Affected January
by Sanghamitra Saha
The month of January witnessed Middle-East tension, the coronavirus outbreak and the return of global growth worries, putting the spotlight on these ETFs.
Apple ETFs to Buy Post Blockbuster Q1 Results
by Sweta Killa
Apple encouraged investors with blockbuster first-quarter fiscal 2020 results, wherein it topped both earnings and revenue estimates and offered an upbeat outlook for the ongoing quarter.
FAANG ETFs in the Spotlight Ahead of Q4 Earnings
by Sweta Killa
The FAANG stocks have been outperforming the market over the past three months buoyed by the initial U.S.-China trade deal. Hopes of better-than-expected earnings releases are also adding to the strength.
China Coronavirus Sells Off Asian Markets
by Mark Vickery
Fears of a new coronavirus coming out of central China caused Asian markets to sell off overnight. Domestic traders appear to be following suit.